Randomized Trials of Cookstoves and Health
Randomized studies testing whether improved or cleaner cookstoves actually reduce illness show mixed results.
SDG 3 Good Health & Well-beingSDG 7 Affordable & Clean EnergyWhat is it?
A body of randomized controlled trials — including the large multi-country HAPIN study — that allocated households to cleaner stoves/fuels and measured exposure and health outcomes.
Why does it matter?
These trials test the causal claim that switching stoves improves health, rather than assuming it from stove specifications alone.
How does it work?
Households are randomly assigned to an intervention or control arm, then followed to compare pollutant exposure and outcomes such as pneumonia, birth weight, or blood pressure.
Who benefits?
Program funders and health agencies benefit from rigorous evidence about which interventions actually deliver, avoiding wasted investment.
Who may be disadvantaged?
Null or modest results can be misread as “cookstoves don’t work,” potentially discouraging support even where cleaner fuels genuinely help.
What evidence exists?
Trials of biomass “improved” stoves often show limited health benefit, largely because exposures stay high; cleaner-fuel (e.g., LPG) interventions like HAPIN cut exposure more but showed mixed primary outcomes.
What tradeoffs exist?
Strong internal validity, but trials are costly, context-specific, and can be confounded by stove stacking and incomplete adherence, complicating generalization.
Common misconceptions
A null health result usually reflects insufficient exposure reduction or mixed stove use, not that clean air is unimportant.
What you can do next
Read how this evidence shapes claims about improved cookstoves.